Literature DB >> 21387947

Effective state-based surveillance for multidrug-resistant organisms related to health care-associated infections.

Jonathan Duffy1, Dawn Sievert, Catherine Rebmann, Marion Kainer, Ruth Lynfield, Perry Smith, Scott Fridkin.   

Abstract

In September 2008, the Council of State and Territorial Epidemiologists and the Centers for Disease Control and Prevention sponsored a meeting of public health and infection-control professionals to address the implementation of surveillance for multidrug-resistant organisms (MDROs)-particularly those related to health care-associated infections. The group discussed the role of health departments and defined goals for future surveillance activities. Participants identified the following main points: (1) surveillance should guide prevention and infection-control activities, (2) an MDRO surveillance system should be adaptable and not organism specific, (3) new systems should utilize and link existing systems, and (4) automated electronic laboratory reporting will be an important component of surveillance but will take time to develop. Current MDRO reporting mandates and surveillance methods vary across states and localities. Health departments that have not already done so should be proactive in determining what type of system, if any, will fit their needs.

Entities:  

Mesh:

Year:  2011        PMID: 21387947      PMCID: PMC3056030          DOI: 10.1177/003335491112600208

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  15 in total

1.  Antibiotic resistance: the Iowa experience.

Authors:  Nancy Bell
Journal:  Am J Manag Care       Date:  2002-11       Impact factor: 2.229

2.  Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-10-17       Impact factor: 17.586

3.  The changing face of surveillance for health care-associated infections.

Authors:  Jerome I Tokars; Chesley Richards; Mary Andrus; Monina Klevens; Amy Curtis; Teresa Horan; John Jernigan; Denise Cardo
Journal:  Clin Infect Dis       Date:  2004-10-06       Impact factor: 9.079

4.  Reduction in central line-associated bloodstream infections among patients in intensive care units--Pennsylvania, April 2001-March 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-10-14       Impact factor: 17.586

5.  Combined antibiogram for hospitals with 50+ beds--Alaska, 2002.

Authors:  Louis Castrodale; Thomas Hennessy
Journal:  Alaska Med       Date:  2004 Oct-Dec

6.  Statewide surveillance for antibiotic-resistant bacteria--New Jersey, 1992-1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-14       Impact factor: 17.586

7.  A statewide surveillance system for antimicrobial-resistant bacteria: New Jersey.

Authors:  S M Paul; L Finelli; G L Crane; K C Spitalny
Journal:  Infect Control Hosp Epidemiol       Date:  1995-07       Impact factor: 3.254

8.  Sentinel surveillance as an alternative approach for monitoring antibiotic-resistant invasive pneumococcal disease in Washington State.

Authors:  D B Jernigan; L Kargacin; A Poole; J Kobayashi
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

9.  Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-08-22       Impact factor: 17.586

10.  Community-acquired methicillin-resistant Staphylococcus aureus among military recruits.

Authors:  Craig E Zinderman; Byron Conner; Mark A Malakooti; James E LaMar; Adam Armstrong; Bruce K Bohnker
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

View more
  1 in total

1.  Creation of State Antibiogram and Subsequent Launch of Public Health-Coordinated Antibiotic Stewardship in New Hampshire: Small State, Big Collaboration.

Authors:  Hannah M Leeman; Benjamin P Chan; Carly R Zimmermann; Elizabeth A Talbot; Michael S Calderwood; Apara R Dave; Paul Santos; Katrina E Hansen
Journal:  Public Health Rep       Date:  2021-03-05       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.